HNGE Hinge Health, Inc.

NYSE www.hingehealth.com


$ 45.43 $ 0.65 (1.44 %)    

Thursday, 20-Nov-2025 12:18:00 EST
QQQ $ 591.96 $ -19.72 (-3.22 %)
DIA $ 459.21 $ -7.47 (-1.6 %)
SPY $ 657.41 $ -15.53 (-2.31 %)
TLT $ 89.32 $ 0.33 (0.38 %)
GLD $ 372.92 $ -2.26 (-0.6 %)
$ 44.1
$ 45.00
$ 45.71 x 100
$ 45.83 x 67
$ 45.00 - $ 47.05
$ 33.42 - $ 62.18
5,591,938
na
3.48B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $61 t...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $62 to $65.

Core News & Articles

Piper Sandler analyst Jessica Tassan reiterates Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from ...

Core News & Articles

Hinge Health (NYSE:HNGE) raises FY2025 sales outlook from $548.000 million-$552.000 million to $572.000 million-$574.000 millio...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q4 sales of $155.000 million-$157.000 million vs $145.468 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by...

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION